Intellia Therapeutics Inc (NASDAQ:NTLA)

81.60
Delayed Data
As of 4:00pm ET
 -1.02 / -1.23%
Today’s Change
43.86
Today|||52-Week Range
202.73
-30.99%
Year-to-Date

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 173.00, with a high estimate of 238.00 and a low estimate of 123.00. The median estimate represents a +112.01% increase from the last price of 81.60.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Buy stock in Intellia Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.94
Sales
$9.0M
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.24%
 
 
 
 
 
 
Growthannually -49.62%
 
 
 
 
 
 

Sales

Growthquarterly 24.40%
 
 
 
 
 
 
Growthannually -49.25%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.